Phase 2 Locally advanced and metastatic pancreatic cancer Clinical Trials
2 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–2 of 2 trials
Recruiting
Phase 1Phase 2
NALIRIFOX+Adebrelimab+PULSAR for Advanced Pancreatic Cancer
Locally advanced and metastatic pancreatic cancerPancreatic Ductal Adenocarcinoma (PDAC)
West China Hospital55 enrolled1 locationNCT07595172
Completed
Phase 2
A randomised phase II study evaluating potential predictive biomarkers in the treatment of locally advanced and metastatic pancreatic cancer
Locally advanced and metastatic pancreatic cancer
Australasian Gastrointestinal Trials Group (AGITG)80 enrolled1 locationACTRN12610001047088